U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758335) titled 'The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757035) titled 'Effects of Low Frequency Whole Body Vibrations on Motor Skills and Sensory Integration in C... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07756996) titled 'Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hy... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07756723) titled 'The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Supported Treatme... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More